Home > Research > Publications & Outputs > Self-efficacy of advanced cancer patients for p...

Research

Links

Text available via DOI:

Keywords

View graph of relations

Self-efficacy of advanced cancer patients for participation in treatment-related decision-making in six European countries: the ACTION study

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Published

Standard

Self-efficacy of advanced cancer patients for participation in treatment-related decision-making in six European countries: the ACTION study. / Yildiz, Berivan; Korfage, Ida J.; Deliens, Luc et al.
In: Supportive Care in Cancer, Vol. 31, No. 9, 30.09.2023.

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Harvard

Yildiz, B, Korfage, IJ, Deliens, L, Preston, NJ, Miccinesi, G, Kodba-Ceh, H, Pollock, K, Johnsen, AT, van Delden, JJM, Rietjens, JAC & van der Heide, A 2023, 'Self-efficacy of advanced cancer patients for participation in treatment-related decision-making in six European countries: the ACTION study', Supportive Care in Cancer, vol. 31, no. 9. https://doi.org/10.1007/s00520-023-07974-2

APA

Yildiz, B., Korfage, I. J., Deliens, L., Preston, N. J., Miccinesi, G., Kodba-Ceh, H., Pollock, K., Johnsen, A. T., van Delden, J. J. M., Rietjens, J. A. C., & van der Heide, A. (2023). Self-efficacy of advanced cancer patients for participation in treatment-related decision-making in six European countries: the ACTION study. Supportive Care in Cancer, 31(9). https://doi.org/10.1007/s00520-023-07974-2

Vancouver

Yildiz B, Korfage IJ, Deliens L, Preston NJ, Miccinesi G, Kodba-Ceh H et al. Self-efficacy of advanced cancer patients for participation in treatment-related decision-making in six European countries: the ACTION study. Supportive Care in Cancer. 2023 Sept 30;31(9). Epub 2023 Aug 8. doi: 10.1007/s00520-023-07974-2

Author

Yildiz, Berivan ; Korfage, Ida J. ; Deliens, Luc et al. / Self-efficacy of advanced cancer patients for participation in treatment-related decision-making in six European countries : the ACTION study. In: Supportive Care in Cancer. 2023 ; Vol. 31, No. 9.

Bibtex

@article{170204d1ec2b4e9183e1efe7e9a2124e,
title = "Self-efficacy of advanced cancer patients for participation in treatment-related decision-making in six European countries: the ACTION study",
abstract = "Purpose: Many patients prefer an active role in making decisions about their care and treatment, but participating in such decision-making is challenging. The aim of this study was to explore whether patient-reported outcomes (quality of life and patient satisfaction), patients{\textquoteright} coping strategies, and sociodemographic and clinical characteristics were associated with self-efficacy for participation in decision-making among patients with advanced cancer. Methods: We used baseline data from the ACTION trial of patients with advanced colorectal or lung cancer from six European countries, including scores on the decision-making participation self-efficacy (DEPS) scale, EORTC QLQ-C15-PAL questionnaire, and the EORTC IN-PATSAT32 questionnaire. Multivariable linear regression analyses were used to examine associations with self-efficacy scores. Results: The sample included 660 patients with a mean age of 66 years (SD 10). Patients had a mean score of 73 (SD 24) for self-efficacy. Problem-focused coping (B 1.41 (95% CI 0.77 to 2.06)), better quality of life (B 2.34 (95% CI 0.89 to 3.80)), and more patient satisfaction (B 7.59 (95% CI 5.61 to 9.56)) were associated with a higher level of self-efficacy. Patients in the Netherlands had a higher level of self-efficacy than patients in Belgium ((B 7.85 (95% CI 2.28 to 13.42)), whereas Italian patients had a lower level ((B −7.50 (95% CI −13.04 to −1.96)) than those in Belgium. Conclusion: Coping style, quality of life, and patient satisfaction with care were associated with self-efficacy for participation in decision-making among patients with advanced cancer. These factors are important to consider for healthcare professionals when supporting patients in decision-making processes.",
keywords = "Self-efficacy, Advanced cancer, Support, Decision-making, Coping",
author = "Berivan Yildiz and Korfage, {Ida J.} and Luc Deliens and Preston, {Nancy J.} and Guido Miccinesi and Hana Kodba-Ceh and Kristian Pollock and Johnsen, {Anna Thit} and {van Delden}, {Johannes J. M.} and Rietjens, {Judith A. C.} and {van der Heide}, Agnes",
year = "2023",
month = sep,
day = "30",
doi = "10.1007/s00520-023-07974-2",
language = "English",
volume = "31",
journal = "Supportive Care in Cancer",
issn = "0941-4355",
publisher = "Springer Verlag",
number = "9",

}

RIS

TY - JOUR

T1 - Self-efficacy of advanced cancer patients for participation in treatment-related decision-making in six European countries

T2 - the ACTION study

AU - Yildiz, Berivan

AU - Korfage, Ida J.

AU - Deliens, Luc

AU - Preston, Nancy J.

AU - Miccinesi, Guido

AU - Kodba-Ceh, Hana

AU - Pollock, Kristian

AU - Johnsen, Anna Thit

AU - van Delden, Johannes J. M.

AU - Rietjens, Judith A. C.

AU - van der Heide, Agnes

PY - 2023/9/30

Y1 - 2023/9/30

N2 - Purpose: Many patients prefer an active role in making decisions about their care and treatment, but participating in such decision-making is challenging. The aim of this study was to explore whether patient-reported outcomes (quality of life and patient satisfaction), patients’ coping strategies, and sociodemographic and clinical characteristics were associated with self-efficacy for participation in decision-making among patients with advanced cancer. Methods: We used baseline data from the ACTION trial of patients with advanced colorectal or lung cancer from six European countries, including scores on the decision-making participation self-efficacy (DEPS) scale, EORTC QLQ-C15-PAL questionnaire, and the EORTC IN-PATSAT32 questionnaire. Multivariable linear regression analyses were used to examine associations with self-efficacy scores. Results: The sample included 660 patients with a mean age of 66 years (SD 10). Patients had a mean score of 73 (SD 24) for self-efficacy. Problem-focused coping (B 1.41 (95% CI 0.77 to 2.06)), better quality of life (B 2.34 (95% CI 0.89 to 3.80)), and more patient satisfaction (B 7.59 (95% CI 5.61 to 9.56)) were associated with a higher level of self-efficacy. Patients in the Netherlands had a higher level of self-efficacy than patients in Belgium ((B 7.85 (95% CI 2.28 to 13.42)), whereas Italian patients had a lower level ((B −7.50 (95% CI −13.04 to −1.96)) than those in Belgium. Conclusion: Coping style, quality of life, and patient satisfaction with care were associated with self-efficacy for participation in decision-making among patients with advanced cancer. These factors are important to consider for healthcare professionals when supporting patients in decision-making processes.

AB - Purpose: Many patients prefer an active role in making decisions about their care and treatment, but participating in such decision-making is challenging. The aim of this study was to explore whether patient-reported outcomes (quality of life and patient satisfaction), patients’ coping strategies, and sociodemographic and clinical characteristics were associated with self-efficacy for participation in decision-making among patients with advanced cancer. Methods: We used baseline data from the ACTION trial of patients with advanced colorectal or lung cancer from six European countries, including scores on the decision-making participation self-efficacy (DEPS) scale, EORTC QLQ-C15-PAL questionnaire, and the EORTC IN-PATSAT32 questionnaire. Multivariable linear regression analyses were used to examine associations with self-efficacy scores. Results: The sample included 660 patients with a mean age of 66 years (SD 10). Patients had a mean score of 73 (SD 24) for self-efficacy. Problem-focused coping (B 1.41 (95% CI 0.77 to 2.06)), better quality of life (B 2.34 (95% CI 0.89 to 3.80)), and more patient satisfaction (B 7.59 (95% CI 5.61 to 9.56)) were associated with a higher level of self-efficacy. Patients in the Netherlands had a higher level of self-efficacy than patients in Belgium ((B 7.85 (95% CI 2.28 to 13.42)), whereas Italian patients had a lower level ((B −7.50 (95% CI −13.04 to −1.96)) than those in Belgium. Conclusion: Coping style, quality of life, and patient satisfaction with care were associated with self-efficacy for participation in decision-making among patients with advanced cancer. These factors are important to consider for healthcare professionals when supporting patients in decision-making processes.

KW - Self-efficacy

KW - Advanced cancer

KW - Support

KW - Decision-making

KW - Coping

U2 - 10.1007/s00520-023-07974-2

DO - 10.1007/s00520-023-07974-2

M3 - Journal article

VL - 31

JO - Supportive Care in Cancer

JF - Supportive Care in Cancer

SN - 0941-4355

IS - 9

ER -